| Revenue growth | 38% YoY growth in Q1 FY27. |
|---|---|
| Margins | Operating margin at 24.2%; ex-Sahyadri hospitals at 25%. |
| Demand visibility | Strong, evidenced by 65% occupancy and 39% IP volume growth. |
| Management confidence | High, citing sustainable volume-led growth and successful greenfield ramp-ups. |
Growth
Revenue grew 38%+ YoY; network EBITDA rose 26%+. Inpatient volumes increased 39% while OP volumes rose 26%.
Outlook
Capex of INR 2,000 Cr planned for FY27; adding 1,000 beds. Targeting 3,000 additional beds over 3-4 years.
Risks
One-off pre-acquisition contract benefits in the prior year and greenfield gestation costs impacted margins slightly.
Investor Presentation filed with BSE, NSE: MANIPALHOS. Summary written with AI assistance from the document.
Manipal Health Enterprises Ltd: key numbers
- Share price
- ₹692.80
- Market cap
- ₹91,129 Cr
- Revenue (annual)
- ₹10,336 Cr
- Net profit (annual)
- ₹892.3 Cr
- Promoter holding
- 72.08%
- FII holding
- 3.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manipal Health Enterprises Ltd
All →Manipal Health Enterprises Share Pledge
Manipal Health Enterprises disclosed a Reg 31(1) encumbrance over 17.43% of promoter shares. The pledge secures up to Rs 500 Crore of Claypond NCDs.
- Value
- ₹500.0 Cr
Manipal Health Enterprises Debt & Borrowing: ₹5,310 Cr
Manipal Health Enterprises Ltd has utilized IPO proceeds for the full redemption of its subsidiary's outstanding listed non-convertible debentures. The total nominal value redeemed is Rs. 5,310 Crore.
- Value
- ₹5,310 Cr
Manipal Health Enterprises Annual General Meeting
Manipal Health Enterprises issued a notice for its 16th Annual General Meeting scheduled for September 29, 2026, to transact ordinary and special business.
Manipal Health Enterprises Share Pledge
Promoters of Manipal Health Enterprises Limited created an encumbrance on 23,21,47,755 shares, representing 17.43% stake. This pertains to covenants under financing documents for NCDs worth Rs.500 Crore.
- Value
- ₹500.0 Cr
Manipal Health Enterprises Other Announcement
Manipal Health Enterprises Limited announced the appointment of Price Waterhouse Chartered Accountants LLP as statutory auditor, effective September 29, 2026, following the tenure completion of BSR & Co. LLP.
Manipal Health Enterprises Investor Presentation: Key Takeaways
Manipal Health delivered its first post-listing results for Q1 FY27, reporting 38.1% revenue growth driven by patient demand and Sahyadri Hospital integration. Strategy focuses on high-acuity specialties and network expansion.